1 |
Yu J, Xie X, Wang L, Liu W, Xu H, Lu X, Li X, Ren J, Li W. Smart Chondroitin Sulfate Micelles for Effective Targeted Delivery of Doxorubicin Against Breast Cancer Metastasis. Int J Nanomedicine 2023;18:663-77. [PMID: 36798532 DOI: 10.2147/IJN.S398802] [Reference Citation Analysis]
|
2 |
Amulya E, Sikder A, Vambhurkar G, Shah S, Khatri DK, Raghuvanshi RS, Singh SB, Srivastava S. Nanomedicine based strategies for oligonucleotide traversion across the blood-brain barrier. J Control Release 2023;354:554-71. [PMID: 36649742 DOI: 10.1016/j.jconrel.2023.01.031] [Reference Citation Analysis]
|
3 |
Famta P, Shah S, Jain N, Srinivasarao DA, Murthy A, Ahmed T, Vambhurkar G, Shahrukh S, Singh SB, Srivastava S. Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics. J Control Release 2023;353:166-85. [PMID: 36423870 DOI: 10.1016/j.jconrel.2022.11.034] [Reference Citation Analysis]
|
4 |
Pathade V, Nene S, Ratnam S, Khatri DK, Raghuvanshi RS, Singh SB, Srivastava S. Emerging insights of peptide-based nanotherapeutics for effective management of rheumatoid arthritis. Life Sci 2022;312:121257. [PMID: 36462722 DOI: 10.1016/j.lfs.2022.121257] [Reference Citation Analysis]
|
5 |
Wen H, Liu P, Jiang Z, Peng H, Liu H. Redox-responsive MXene-SS-PEG nanomaterials for delivery of doxorubicin. Inorganic Chemistry Communications 2022. [DOI: 10.1016/j.inoche.2022.110227] [Reference Citation Analysis]
|
6 |
Vambhurkar G, Amulya E, Sikder A, Shah S, Famta P, Khatri DK, Singh SB, Srivastava S. Nanomedicine based Potentially Transformative Strategies for Colon Targeting of Peptides: State-of-the-art. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|